Medicine and Dentistry
Venous Thromboembolism
100%
Fibrinolysis
76%
Biological Marker
73%
Hematology
66%
Atrial Fibrillation
66%
Bleeding
44%
Brain Ischemia
44%
Apoplexy
38%
Anticoagulant Therapy
38%
Fibrin Clot
38%
Clinician
38%
Systematic Review
36%
Venous Blood
33%
Sex Difference
33%
Meta-Analysis
33%
Endothelial Function
33%
Anticoagulant
33%
Randomized Controlled Trial
33%
Orthognathic Surgery
33%
Low Molecular Weight Heparin
33%
Phlebothrombosis
33%
C Reactive Protein
31%
Tranexamic Acid
27%
Plasminogen Activator Inhibitor-1
26%
Thrombin
24%
Hemostat
22%
Anticoagulation
22%
Von Willebrand Factor
20%
Albumin
20%
Fibrinogen
17%
Alteplase
16%
Prevalence
15%
Health Care
13%
Thrombophilia
13%
Tissue Plasminogen Activator
13%
Subgroup Analysis
11%
Antithrombotic
11%
Body Weight
11%
Prothrombinase
11%
Blood Clotting
11%
Vitamin K Antagonist
11%
Acetylsalicylic Acid
11%
Comorbidity
11%
Trypsin Inhibitor
6%
Serum Albumin
6%
Retrospective Study
6%
Contralateral
6%
Cardiovascular Risk
6%
Vein Puncture
6%
Thrombin Time
6%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
92%
Fibrinolytic Agent
66%
Thrombin
66%
Plasminogen Activator Inhibitor 1
47%
Von Willebrand Factor
46%
Cardiovascular Disease
40%
C Reactive Protein
33%
Antivitamin K
33%
Anticoagulant Agent
33%
Brain Ischemia
33%
Inflammation
33%
Vein Thrombosis
33%
Albumin
33%
Venous Thromboembolism
27%
Tissue Plasminogen Activator
23%
Cardiovascular Risk
21%
Hemostatic Agent
20%
Plasminogen Activator
13%
Thrombophilia
11%
Serum Albumin
11%
Normal Human
11%
Trypsin Inhibitor
11%
Prevalence
9%
Retinol
8%
Prospective Study
8%
Arterial Thromboembolism
5%
Plasminogen
5%
Fibrinogen
5%
Artery Thrombosis
5%
Retrospective Study
5%
Biochemistry, Genetics and Molecular Biology
Tissue Plasminogen Activator
58%
Fibrinolysis
50%
Phlebothrombosis
33%
Sex Difference
33%
Biomarker Validation
33%
Fibrin Polymerization
33%
Endurance Training
33%
VKORC1
33%
Atrial Fibrillation
33%
Allele
33%
Gene Sequence
33%
CYP2C9
33%
Plasminogen Activator Inhibitor-1
25%
Decision Making
16%
Intestine Flora
16%
Thrombophilia
16%
Metabolite
16%
Metabolomics
16%
Metagenomics
16%
Tamsulosin
16%
Artificial Intelligence
16%
Genomics
16%
Blood Plasma
15%
Physical Activity
13%
Maximum Reaction Velocity
11%
Coagulation System
11%
Prevalence
8%
Genetic Polymorphism
8%
Retrospective Study
8%
Fibrinogen
8%
Sedentary Lifestyle
6%
Body Weight
6%
Fat Mass
6%
Body Fat
6%
Fibrin Clot
5%
Systolic Blood Pressure
5%
Cardiac Dysrhythmia
5%
CYP2C9*3
5%
Vitamin K
5%
Low Drug Dose
5%
Genotyping
5%
Prospective Study
5%
